The CEO/Founder of Blackswan Diagnostics, Jack Bensimon, also has solid medical research connections in Israel:
"Jack chairs the Technion Canada Endowment Fund on behalf of the Technion-Israel Institute of Technology, a leading engineering university/medical school, with investment returns funding innovative lab projects."
This could be another reason, aside from expedition, as to how/why MYDX chose to engage in clinical trials in Israel.
http://www.blackswandiagnostics.com/management/
"Jack chairs the Technion Canada Endowment Fund on behalf of the Technion-Israel Institute of Technology, a leading engineering university/medical school, with investment returns funding innovative lab projects."
This could be another reason, aside from expedition, as to how/why MYDX chose to engage in clinical trials in Israel.
http://www.blackswandiagnostics.com/management/